Selected research
Industry Research
Capecitabine Tablets Industry Research Report 2026
Market perspective
The global Capecitabine Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Capecitabine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Capecitabine Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Capecitabine Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Capecitabine Tablets include Chia Tai-Tianqing Pharmaceutical, Chengdu Easton Biopharmaceuticals, Shanghai Sine Pharmaceutical, Shandong New Time Pharmaceutical, Qilu Pharmaceutical, Roche, Teva Pharmaceutical, Sun Pharma and Eugia Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Capecitabine Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Capecitabine Tablets Market by Company
Chia Tai-Tianqing Pharmaceutical
Chengdu Easton Biopharmaceuticals
Shanghai Sine Pharmaceutical
Shandong New Time Pharmaceutical
Qilu Pharmaceutical
Roche
Teva Pharmaceutical
Sun Pharma
Eugia Pharma
Dr. Reddy's Laboratories
Accord Healthcare
Capecitabine Tablets Segment by Type
150mg
500mg
Capecitabine Tablets Segment by Application
Colon Cancer
Breast Cancer
Stomach Cancer
Capecitabine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Capecitabine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Capecitabine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Capecitabine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Capecitabine Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Capecitabine Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Capecitabine Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 150mg
- 500mg
Applications
- Colon Cancer
- Breast Cancer
- Stomach Cancer
Companies covered
- Chia Tai-Tianqing Pharmaceutical
- Chengdu Easton Biopharmaceuticals
- Shanghai Sine Pharmaceutical
- Shandong New Time Pharmaceutical
- Qilu Pharmaceutical
- Roche
- Teva Pharmaceutical
- Sun Pharma
- Eugia Pharma
- Dr. Reddy's Laboratories
- Accord Healthcare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Capecitabine Tablets Market Size (2021-2032)
- 2.2.2 Global Capecitabine Tablets Sales (2021-2032)
- 2.2.3 Global Capecitabine Tablets Market Average Price (2021-2032)
- 2.3 Capecitabine Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 150mg
- 2.3.3 500mg
- 2.4 Capecitabine Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Colon Cancer
- 2.4.3 Breast Cancer
- 2.4.4 Stomach Cancer
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Capecitabine Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Capecitabine Tablets Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Capecitabine Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Capecitabine Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Capecitabine Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Capecitabine Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Capecitabine Tablets, Product Type & Application
- 3.8 Global Manufacturers of Capecitabine Tablets, Established Date
- 3.9 Global Capecitabine Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chia Tai-Tianqing Pharmaceutical
- 4.1.1 Chia Tai-Tianqing Pharmaceutical Company Information
- 4.1.2 Chia Tai-Tianqing Pharmaceutical Business Overview
- 4.1.3 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chia Tai-Tianqing Pharmaceutical Capecitabine Tablets Product Portfolio
- 4.1.5 Chia Tai-Tianqing Pharmaceutical Recent Developments
- 4.2 Chengdu Easton Biopharmaceuticals
- 4.2.1 Chengdu Easton Biopharmaceuticals Company Information
- 4.2.2 Chengdu Easton Biopharmaceuticals Business Overview
- 4.2.3 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Chengdu Easton Biopharmaceuticals Capecitabine Tablets Product Portfolio
- 4.2.5 Chengdu Easton Biopharmaceuticals Recent Developments
- 4.3 Shanghai Sine Pharmaceutical
- 4.3.1 Shanghai Sine Pharmaceutical Company Information
- 4.3.2 Shanghai Sine Pharmaceutical Business Overview
- 4.3.3 Shanghai Sine Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Sine Pharmaceutical Capecitabine Tablets Product Portfolio
- 4.3.5 Shanghai Sine Pharmaceutical Recent Developments
- 4.4 Shandong New Time Pharmaceutical
- 4.4.1 Shandong New Time Pharmaceutical Company Information
- 4.4.2 Shandong New Time Pharmaceutical Business Overview
- 4.4.3 Shandong New Time Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shandong New Time Pharmaceutical Capecitabine Tablets Product Portfolio
- 4.4.5 Shandong New Time Pharmaceutical Recent Developments
- 4.5 Qilu Pharmaceutical
- 4.5.1 Qilu Pharmaceutical Company Information
- 4.5.2 Qilu Pharmaceutical Business Overview
- 4.5.3 Qilu Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Qilu Pharmaceutical Capecitabine Tablets Product Portfolio
- 4.5.5 Qilu Pharmaceutical Recent Developments
- 4.6 Roche
- 4.6.1 Roche Company Information
- 4.6.2 Roche Business Overview
- 4.6.3 Roche Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Roche Capecitabine Tablets Product Portfolio
- 4.6.5 Roche Recent Developments
- 4.7 Teva Pharmaceutical
- 4.7.1 Teva Pharmaceutical Company Information
- 4.7.2 Teva Pharmaceutical Business Overview
- 4.7.3 Teva Pharmaceutical Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Teva Pharmaceutical Capecitabine Tablets Product Portfolio
- 4.7.5 Teva Pharmaceutical Recent Developments
- 4.8 Sun Pharma
- 4.8.1 Sun Pharma Company Information
- 4.8.2 Sun Pharma Business Overview
- 4.8.3 Sun Pharma Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharma Capecitabine Tablets Product Portfolio
- 4.8.5 Sun Pharma Recent Developments
- 4.9 Eugia Pharma
- 4.9.1 Eugia Pharma Company Information
- 4.9.2 Eugia Pharma Business Overview
- 4.9.3 Eugia Pharma Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Eugia Pharma Capecitabine Tablets Product Portfolio
- 4.9.5 Eugia Pharma Recent Developments
- 4.10 Dr. Reddy's Laboratories
- 4.10.1 Dr. Reddy's Laboratories Company Information
- 4.10.2 Dr. Reddy's Laboratories Business Overview
- 4.10.3 Dr. Reddy's Laboratories Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Dr. Reddy's Laboratories Capecitabine Tablets Product Portfolio
- 4.10.5 Dr. Reddy's Laboratories Recent Developments
- 4.11 Accord Healthcare
- 4.11.1 Accord Healthcare Company Information
- 4.11.2 Accord Healthcare Business Overview
- 4.11.3 Accord Healthcare Capecitabine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Accord Healthcare Capecitabine Tablets Product Portfolio
- 4.11.5 Accord Healthcare Recent Developments
5 Global Capecitabine Tablets Market Scenario by Region
- 5.1 Global Capecitabine Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Capecitabine Tablets Sales by Region: 2021-2032
- 5.2.1 Global Capecitabine Tablets Sales by Region: 2021-2026
- 5.2.2 Global Capecitabine Tablets Sales by Region: 2027-2032
- 5.3 Global Capecitabine Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Capecitabine Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Capecitabine Tablets Revenue by Region: 2027-2032
- 5.4 North America Capecitabine Tablets Market Facts & Figures by Country
- 5.4.1 North America Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Capecitabine Tablets Sales by Country (2021-2032)
- 5.4.3 North America Capecitabine Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Capecitabine Tablets Market Facts & Figures by Country
- 5.5.1 Europe Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Capecitabine Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Capecitabine Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Capecitabine Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Capecitabine Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Capecitabine Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Capecitabine Tablets Market Facts & Figures by Country
- 5.7.1 South America Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Capecitabine Tablets Sales by Country (2021-2032)
- 5.7.3 South America Capecitabine Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Capecitabine Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Capecitabine Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Capecitabine Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Capecitabine Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Capecitabine Tablets Sales by Type (2021-2032)
- 6.1.1 Global Capecitabine Tablets Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Capecitabine Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Capecitabine Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Capecitabine Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Capecitabine Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Capecitabine Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Capecitabine Tablets Sales by Application (2021-2032)
- 7.1.1 Global Capecitabine Tablets Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Capecitabine Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Capecitabine Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Capecitabine Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Capecitabine Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Capecitabine Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Capecitabine Tablets Value Chain Analysis
- 8.1.1 Capecitabine Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Capecitabine Tablets Production Mode & Process
- 8.2 Capecitabine Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Capecitabine Tablets Distributors
- 8.2.3 Capecitabine Tablets Customers
9 Global Capecitabine Tablets Analyzing Market Dynamics
- 9.1 Capecitabine Tablets Industry Trends
- 9.2 Capecitabine Tablets Industry Drivers
- 9.3 Capecitabine Tablets Industry Opportunities and Challenges
- 9.4 Capecitabine Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst